1 / 29

Insulin and the integrity of nerve fibre

Insulin and the integrity of nerve fibre. Dr MV Srishyla Regional medical director Novo Nordisk India. 3 rd DFSI conference, Jaipur, India 12 Sep 2004. 3 rd annual conference, Diabetic Foot Society of India, Jaipur, India. 12 Sep 2004. Nerve electrophysiology & morphology

paloma
Download Presentation

Insulin and the integrity of nerve fibre

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Insulin and the integrity of nerve fibre Dr MV Srishyla Regional medical director Novo Nordisk India 3rd DFSI conference, Jaipur, India 12 Sep 2004 3rd annual conference, Diabetic Foot Society of India, Jaipur, India. 12 Sep 2004

  2. Nerve electrophysiology & morphology • Animal studies • Clinical studies

  3. Nerve electrophysiology(1) • Nerve conduction studies • NCV most sensitive index of severity of DSP • NAPA index of degree of fiber loss • Relationship between DSP and risk factors • Pittsburgh epidemiology of diab complications study, 1989 • DCCT, 1993 • EURODIAB type 1 complications study, 1996 • Seattle prospective diabetic foot study, 1997 • Focus on identifying risk factors for presence of DSP

  4. Nerve electrophysiology(2) • Tkac I and Bril V. Diabetes Care Oct 1998 • Studied the value of GHb, duration, age, sex and height in predicting the electrophysiologic severity of DSP • Used different models of severity • GHb significantly related to severity • GHb cut-off for highest predictive value • GHb < 9% vs > 9% (poor control) • Mean SNCV & SAMP 6.3% & 18% lower resp in poorly controlled • Corresponds with that achieved in DCCT

  5. Nerve morphology • Perkins B, Greene D and Bril V. Diabetes Care Apr 2001 • Studied the value of GHb, duration, age, sex and height in predicting the morphologic severity of DSP • Used different models of severity • GHb significantly related to severity • GHb cut-off for highest predictive value • GHb < 9% vs > 9% (poor control) • Mean FD 33% (3461 Vs 2334) lower in poorly controlled

  6. Nerve electrophysiology & morphology • Animal studies • Clinical studies

  7. Study 1 • Brussee V, Cunningham FA and Zochodne DW, Diabetes July 2004 “Direct insulin signaling of neurons reverses DN” • Benefits of insulin independent of glycemia • Provides direct support for neurons and peripheral axons • Low doses – reverse conduction slowing (abnormal function) and axonal atrophy (abnormal structure)

  8. Insulin had the capability of signaling sensory neurons FITC-labelled insulin (intrathecal) accessed and labeled individual lumbar dorsal root ganglion neurons. Study 1: Neurons express insulin receptors Immunofluoroscence Light Saline inj L4-6 DRG Neurons Insulin inj Non-diabetic rats

  9. Study 1: Insulin improves conduction abnormalities Sciatic-tibial motor Higher dose of insulin completely reversed slowing of sensory nerve conduction Caudal sensory

  10. Study 1: Insulin prevents axonal atrophy Control rat 22.7 18.4 Diabetic rat Myelinated sural sensory nerve sections Insulin reversed distal sensory axonal atrophy

  11. Study 1: Effect of anti-insulin antibody Sequestering endogenous insulin generates axonal abnormalities Non-diabetic rats

  12. Study 2 • Zochodne DW, Sun H and Eyer J, Brain Aug 2004 “Accelerated DN in axons without neurofilaments” • Beneficial effects of insulin on axons when neurofilaments (critical latticework of axons) are damaged • Superimposed STZ-diabetes on transgenic mouse model with deficient Nf-H protein • Nf-replete and Nf-deficient diabetic and non-diabetic mice

  13. Study 2: Neurofilament deficiency accelerates diabetic neuropathy - NCV Diabetic mice lacking neurofilaments, Nf-dia+, show a decline in CV betn 4 and 8 weeks of diabetes

  14. Study 2: Neurofilament deficiency accelerates diabetic neuropathy - Amplitude

  15. Study 2: Effect of insulin – electrophysiology and morphology Nf-Dia+ mice Non-Neurofilament related actions – e.g new protein synthesis, mitochondrial target etc

  16. Study 3 • Huang et al, Diabetes, Aug 2003 “Insulin prevents depolarization of mitochondrial membrane in the presence of sustained hyperglycemia” • Effect of insulin on mitochondrial membrane • Mitochondrial dysfunction • depolarization / membrane potential measured as whole-cell fluorescent video imaging using rhodamine 123 (R123) • CCCP ~ Carbonyl cyanide chlorophenylhydrazone

  17. Study 3: Insulin prevents diabetes-induced mitochondrial dysfunction

  18. Study 3: Insulin action independent of blood glucose levels Sensory neuron cultures were treated for 6 or 24 h with and without 1.0 nM insulin and mitochondrial polarization status calculated Sensory neuron cultures were treated for 24 h with 10 or 50 mM glucose and with / without 1.0 nM insulin and mitochondrial polarization status calculated

  19. Study 3: Insulin action independent of blood glucose levels

  20. Summary animal studies • Insulin signals neurons directly and has distal protective effects • Insulin prevents axonal loss and atrophy through non-neurofilament related actions • Insulin prevents depolarization of mitochondrial membrane in sensory neurons

  21. Nerve electrophysiology & morphology • Animal studies • Clinical studies

  22. Studies of intensive insulin therapy • DCCT, follow-up 6.5 years • Oslo study, follow-up18 years

  23. DCCT study • Intensive therapy reduced • Confirmed clinical neuropathy by 64% • Abnormal nerve conduction by 44% • Abnormal autonomic function by 53% • Nerve conduction velocities • Remained stable with intensive therapy • Decreased significantly with conventional 13% 5% Ann Intern Med 1995;122:561-8

  24. Oslo study • HbA1c strong predictor of nerve function • HbA1c<8.4% over 18 years assoc with near normal nerve function Diabetes Care 2003;26:2400-4

  25. Conclusion

  26. Diabetic neuropathy - Mechanisms Insulin restores balance between Nerve degeneration and regeneration

  27. Diabetic neuropathy - Mechanisms • Insulin • ↓ • Survival response mechanisms • ↓ • PI3-kinase • ↓ • PKB/Akt • ↓ • Expression/translocation • of proapoptotic • factors • e.g Bcl-2 proteins

  28. NN India Experience Int J Diab Dev Countries 2001;21:133-7;Data on file, 2000; Novo Nordisk Diabetes Update, March 21-23, Colombo, Srilanka 2003: 80-92; iSTART meeting, Rome, 7 May 2004

  29. Thank You

More Related